Interestingly, a recent study by Corica et al. (2021) found that asprosin serum levels were significantly lower in children with obesity, and that fasting asprosin decreased with increasing BMI, although it was not significantly affected by insulin resistance [51]. The gene discussed is INS; the disease is obesity disorder.